Elevance Health, INC. 8-K Filing
Ticker: ELV · Form: 8-K · Filed: Nov 10, 2025 · CIK: 1156039
Sentiment: neutral
Filing Stats: 1,299 words · 5 min read · ~4 pages · Grade level 16.6 · Accepted 2025-11-10 17:03:08
Key Financial Figures
- $0.01 — ch registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark whe
- $24.70 — for full year 2025 to be approximately $24.70 per diluted share, including approximat
- $5.30 — diluted share, including approximately $5.30 per diluted share of net unfavorable it
- $30.00 — reholders' earnings to be approximately $30.00 per diluted share. This does not includ
Filing Documents
- elv-20251110.htm (8-K) — 30KB
- 0001156039-25-000139.txt ( ) — 172KB
- elv-20251110.xsd (EX-101.SCH) — 2KB
- elv-20251110_def.xml (EX-101.DEF) — 14KB
- elv-20251110_lab.xml (EX-101.LAB) — 24KB
- elv-20251110_pre.xml (EX-101.PRE) — 15KB
- elv-20251110_htm.xml (XML) — 3KB
FORWARD-LOOKING STATEMENTS
FORWARD-LOOKING STATEMENTS This document contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect our views about future events and financial performance and are generally not historical facts. Words such as "expect," "feel," "believe," "will," "may," "should," "anticipate," "intend," "estimate," "project," "forecast," "plan" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to: financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. You are also urged to carefully review and consider the various risks and other disclosures discussed in our reports filed with the U.S. Securities and Exchange Commission from time to time, which attempt to advise interested parties of the factors that affect our business. Except to the extent required by law, we do not update or revise any forward-looking statements to reflect events or circumstances occurring after the date hereof. These risks and uncertainties include, but are not limited to: trends in healthcare costs and utilization rates; reduced enrollment; our ability to secure and implement sufficient premium rates; the impact of large scale medical emergencies, such as public health epidemics and pandemics, and other catastrophes; the impact of new or changes in existing federal, state and internat